27.03.2024 • News

Chemours Names Denise Dignam Permanent CEO

US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately.

Dignam has been interim CEO since the end of February, when former CEO Mark Newman was placed on administrative leave following an internal investigation.

Dignam joined Chemours in 2015. She brings over 35 years of experience in the chemical industry where she has held senior roles in business and operations, sales and marketing, commercialization, and supply chain. Prior to her role as interim CEO of Chemours, she was president of the Titanium Technologies (TT) segment, and president of the Advanced Performance Materials (APM) segment.

Denise Dignam, CEO, Chemours. Source: Chemours
Denise Dignam, CEO, Chemours. Source: Chemours

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.